# K061754: Bard Composite L/P Mesh

- Pathway: 510(k) (Traditional)
- Applicant: Davol Inc., Sub. C. R. Bard, Inc.
- Decided: Oct 23, 2006 after 124 days
- Product code: FTL (Mesh, Surgical, Polymeric)
- Device class: 2
- Regulation: 21 CFR 878.3300
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K002684 (2000). 3 ancestors in all.
14 later devices descend from it; 4 cite it directly.
0 of 18 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K052155: Bard Large Pore Soft Mesh and Soft Mesh Preshaped, C.R. Bard, Inc. (2005) Summary page 1.
- K002684: Composix E/X Mesh, C.R. Bard, Inc. (2000) Summary page 1.
- K041641: Davol Delivery System, C.R. Bard, Inc. (2004) Summary page 1.

## Most influential descendants
- K092726: Mesh GPS - Large, Small, SM, SM Small (2010), 7 descendants of its own
- K102766: Composix L/P Mesh with Echo PS Positioning System (2010), 6 descendants of its own
- K110820: Ventralight (TM) ST Mesh with Echo PS (TM) Positioning System (2011), 5 descendants of its own
- K122436: Composix L/P Mesh with Echo PS Positioning System Ventralight ST Mesh with Echo PS Positioning System (2012), 4 descendants of its own
- K130968: Ventralight ST Mesh with Echo PS Positioning System (2013), 3 descendants of its own

## Indications for use
Bard Composix L/P Mesh is indicated for use in the reconstruction of soft tissue deficiencies, such as for the repair of hernias and chest wall defects.

Source page: https://510kreport.com/device/K061754
Methodology: https://510kreport.com/methodology